Health Care

Innovative ETFs Channel

Healthcare Providers ETF Breaks Out After White House Ends Drug Rebate Rule

By Max ChenJuly 11, 2019

Innovative ETFs Channel

Biotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing Rule

By Max ChenJuly 9, 2019

Tactical Allocation Channel

ETF of the Week: Robo Global Healthcare Technology and Innovation ETF (HTEC)

By Ben HernandezJuly 9, 2019

Alternatives Channel

Sector ETFs Most at Risk of Earning Disappointments Ahead

By Max ChenJuly 2, 2019

Webcasts

Webcast: Investing in Healthcare Tech & Innovation

By Max ChenJune 25, 2019

Innovative ETFs Channel

4 ARK ETFs to Help Investors Access Innovative Disruptors

By Max ChenJune 21, 2019

Innovative ETFs Channel

Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal

By Max ChenJune 17, 2019

Leveraged & Inverse Channel

Health Care ETFs Could be Cure for Trade War Blues

By Ben HernandezMay 29, 2019

Innovative ETFs Channel

Legal Troubles Beset Pharmaceutical Sector ETFs

By Max ChenMay 14, 2019

Innovative ETFs Channel

Look to Healthcare ETFs for Stability in a Shaky Market

By Max ChenMay 10, 2019

Innovative ETFs Channel

3 Biotech Sector ETFs Bucked the Risk-Off Trend

By Max ChenMay 6, 2019

Equity ETF Channel

17 Highly Targeted Sector ETFs for Late Business Cycle

By Max ChenMay 1, 2019

Webcasts

How Sectors Can Help with a Changing Market

By Max ChenApril 30, 2019

Innovative ETFs Channel

Pharmaceutical ETFs Catch Healthcare Contagion

By Max ChenApril 18, 2019

Innovative ETFs Channel

Healthcare, Biotech ETFs Plunge on Mounting Political Pressures

By Max ChenApril 18, 2019

Innovative ETFs Channel

Healthcare ETFs Lag the Broader Market Amidst Regulation Scare

By Max ChenApril 15, 2019

Equity ETF Channel

Tom Lydon on CNBC: Can Health Care Cure Itself?

By Ben HernandezApril 15, 2019

Relative Value Channel

Will Tighter Government Regulation Test Health Care ETFs?

By Ben HernandezApril 15, 2019